Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $4.93 Billion |
|---|---|
| Enterprise Value | $4.92 Billion |
| Earnings per Share | $-1.37 |
| Beta | 2.02 |
| Outstanding Shares | 86,398,778 |
| P/E Ratio | -39.94 |
|---|---|
| PEG | -56.1 |
| Price to Sales | 29.53 |
| Price to Book Ratio | 19.68 |
| Enterprise Value to Revenue | 23.22 |
| Enterprise Value to EBIT | -42.82 |
| Enterprise Value to Net Income | -42 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.1 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 34.04% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.30%▼ 20.09% |
|---|---|
| Total Invested | $12.58M▼ 99.43% |
| Investors Holding | 28▼ 172.00% |
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial inte...
Stockcircle shows 24 open-market insider sales for Heartflow Common Stock in the last six months from SEC Form 4 reports by executives, directors, and other insiders.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.